Adagene Inc (ADAG US)

Analysis

Health Care • China

Adagene Inc. operates as a biotechnology company. The Company focuses on the development of antibodies to cancer patients. Adagene serves patients in the United States and China.

Refresh

Exchange Announcement • 03 Apr 2026 04:25

424B5 | Prospectus

Exchange Announcement • 02 Apr 2026 19:01

424B5 | Prospectus

Exchange Announcement • 10 Jan 2026 05:34

424B3 | Prospectus

Exchange Announcement • 31 May 2025 05:05

424B5 | Prospectus

Exchange Announcement • 30 Mar 2024 03:33

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00